Bo Han

Summary

Affiliation: Wakayama Medical University
Country: Japan

Publications

  1. ncbi Combined small-cell carcinoma of the stomach: p53 and K-ras gene mutational analysis supports a monoclonal origin of three histological components
    Bo Han
    Department of Pathology, Wakayama Medical University, Wakayama 641 8509, Japan
    Int J Exp Pathol 86:213-8. 2005
  2. ncbi Myoepithelial carcinoma arising in an adenomyoepithelioma of the breast: case report with immunohistochemical and mutational analysis
    Bo Han
    Department of Pathology, Wakayama Medical University, Kimiidera, Wakayama, Japan
    Pathol Int 56:211-6. 2006
  3. ncbi Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers
    Misa Nakamura
    Department of Pathology, Wakayama Medical University, Kimiidera 811 1, Wakayama 641 0012, Japan
    J Mol Endocrinol 39:375-84. 2007
  4. ncbi Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor
    Bo Han
    Department of Pathology, Wakayama Medical University, Wakayama 641-8509, Japan
    Int J Oncol 28:807-14. 2006
  5. ncbi Expression of calcitonin receptor in rat mammary gland during lactation
    Aiko Ishii
    Department of Pathology, Wakayama Medical University, Wakayama, Japan
    Endocr J 53:317-24. 2006
  6. ncbi Urokinase-type plasminogen activator system and breast cancer (Review)
    Bo Han
    Department of Pathology, Wakayama Medical University, Kimiidera 811-1, Wakayama 641-8509, Japan
    Oncol Rep 14:105-12. 2005
  7. ncbi Adrenomedullin: a tumor progression factor via angiogenic control
    Misa Nakamura
    Department of Pathology, Wakayama Medical University, 811 1 Kimiidera, Wakayama, 641 8509, Japan
    Curr Cancer Drug Targets 6:635-43. 2006
  8. ncbi Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
    Scott A Tomlins
    Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
    Nature 448:595-9. 2007
  9. ncbi Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases
    Rohit Mehra
    Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
    Cancer Res 67:7991-5. 2007
  10. ncbi Central malignant salivary gland tumors of the jaw: retrospective clinical analysis of 22 cases
    Yi Li
    Department of Oral and Maxillofacial Surgery, West China College of Stomatology, Sichuan University, Chengdu, China
    J Oral Maxillofac Surg 66:2247-53. 2008

Collaborators

  • Misa Nakamura
  • Ichiro Mori
  • Xiaojuan Wang
  • Gengyin Zhou
  • Osamu Nunobiki
  • Scott A Tomlins
  • Rohit Mehra
  • Yi Li
  • Arul M Chinnaiyan
  • James E Montie
  • Rajal B Shah
  • Lei Wang
  • Anjana Menon
  • Aiko Ishii
  • Long Jiang Li
  • Jian Pan
  • Ju Huang
  • Long-jiang Li
  • Matthew J Wasco
  • Beth E Helgeson
  • Sooryanarayana Varambally
  • Jindan Yu
  • Bharathi Laxman
  • Xuhong Cao
  • Kenneth J Pienta
  • Saravana M Dhanasekaran
  • Diane Roulston
  • Xiaojun Jing
  • Qi Cao
  • Ronglai Shen
  • Mark A Rubin
  • David S Morris
  • Atsushi Nakamura
  • Koichi Takeda
  • Kennichi Kakudo

Detail Information

Publications10

  1. ncbi Combined small-cell carcinoma of the stomach: p53 and K-ras gene mutational analysis supports a monoclonal origin of three histological components
    Bo Han
    Department of Pathology, Wakayama Medical University, Wakayama 641 8509, Japan
    Int J Exp Pathol 86:213-8. 2005
    ..Our results strongly support a hypothesis that the combined SmCC of stomach in this case was of monoclonal origin...
  2. ncbi Myoepithelial carcinoma arising in an adenomyoepithelioma of the breast: case report with immunohistochemical and mutational analysis
    Bo Han
    Department of Pathology, Wakayama Medical University, Kimiidera, Wakayama, Japan
    Pathol Int 56:211-6. 2006
    ..No mutations in exons 1 and 2 of the K-, H-, and N-ras genes were identified in any of the neoplastic component. To the authors' knowledge this is the first report of a mutation in the p53 gene in a malignant AME of the breast...
  3. ncbi Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers
    Misa Nakamura
    Department of Pathology, Wakayama Medical University, Kimiidera 811 1, Wakayama 641 0012, Japan
    J Mol Endocrinol 39:375-84. 2007
    ..These novel findings indicate that CT may be used to target ERK in the treatment of cancer...
  4. ncbi Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor
    Bo Han
    Department of Pathology, Wakayama Medical University, Wakayama 641-8509, Japan
    Int J Oncol 28:807-14. 2006
    ..To the best of our knowledge, this is the first report describing a direct effect of CT on breast cancer cell invasion. Our data might suggest a close link between CT signaling, the uPA-mediated pathway, and breast cancer invasion...
  5. ncbi Expression of calcitonin receptor in rat mammary gland during lactation
    Aiko Ishii
    Department of Pathology, Wakayama Medical University, Wakayama, Japan
    Endocr J 53:317-24. 2006
    ..These results suggest that up-regulation of CTR during lactation may contribute to inhibition of mammary epithelial cell proliferation...
  6. ncbi Urokinase-type plasminogen activator system and breast cancer (Review)
    Bo Han
    Department of Pathology, Wakayama Medical University, Kimiidera 811-1, Wakayama 641-8509, Japan
    Oncol Rep 14:105-12. 2005
    ..Correlations of the uPA system with other informative markers of breast cancer are also discussed...
  7. ncbi Adrenomedullin: a tumor progression factor via angiogenic control
    Misa Nakamura
    Department of Pathology, Wakayama Medical University, 811 1 Kimiidera, Wakayama, 641 8509, Japan
    Curr Cancer Drug Targets 6:635-43. 2006
    ..The major focus of this review will be on the role of ADM in cancer, with emphasis on its utility in diagnostic and prognostic terms, along with its relevance as a therapeutic target...
  8. ncbi Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
    Scott A Tomlins
    Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
    Nature 448:595-9. 2007
    ..Furthermore, the identification of androgen-repressed and insensitive 5' fusion partners may have implications for the anti-androgen treatment of advanced prostate cancer...
  9. ncbi Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases
    Rohit Mehra
    Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
    Cancer Res 67:7991-5. 2007
    ..Understanding this molecular heterogeneity is critical to the future development and utility of diagnostic and prognostic PCA biomarkers...
  10. ncbi Central malignant salivary gland tumors of the jaw: retrospective clinical analysis of 22 cases
    Yi Li
    Department of Oral and Maxillofacial Surgery, West China College of Stomatology, Sichuan University, Chengdu, China
    J Oral Maxillofac Surg 66:2247-53. 2008
    ..As a review of central malignant salivary gland tumor cases in Southwest China in the past 20 years, this study provided the clinical, radiologic, and pathologic information of these rare lesions...